A sizable investor in Allergan Inc doesnt favor the offer Valeant Pharmaceuticals International Inc has made for the Botox maker in conjunction with activist William Ackman  Dan Davidowitz the chief investment officer of Polen Capital Management LLC said Thursday in an interview We think we could get this type of price just from another couple of years of compound earnings growth So I dont think this is that attractive of an offer